Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €12.06 EUR
Change Today -0.448 / -3.58%
Volume 0.0
AB3A On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 3:11 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - sarepta therapeutics inc (AB3A)

Name (Connections)Board RelationshipsTitleKey Developments
John Hodgman B.S., M.B.A. 5 RelationshipsInterim Chairman, Chairman of Audit Committee and Member of Compensation Committee 
William Goolsbee 5 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 
Anthony Chase 185 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 

Compensation Committee* - sarepta therapeutics inc (AB3A)

Name (Connections)Board RelationshipsTitle
William Goolsbee 5 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
John Hodgman B.S., M.B.A. 5 RelationshipsInterim Chairman, Chairman of Audit Committee and Member of Compensation Committee
Gil Price M.D. 12 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
AB3A Compensation vs. Industry
377.7K
365.4K
Chief Executive Officer
427.2K
261.0K
Chief Financial Officer
Share price activity for SAREPTA THERAPEUTICS INC (AB3A)
52 Week Price Performance
AB3A
Industry Average

Nominating Committee* - sarepta therapeutics inc (AB3A)

Name (Connections)Board RelationshipsTitleKey Developments
Gil Price M.D. 12 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Compensation CommitteeSarepta Therapeutics, Inc. Announces Management Changes
04/1/15
Hans Wigzell M.D., Ph.D. 134 RelationshipsChairman of the Corporate Strategy Board, Director and Member of Nominating & Corporate Governance CommitteeSarepta Therapeutics, Inc. Announces Executive Changes
07/31/14
Anthony Chase 185 RelationshipsDirector, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteeSarepta Therapeutics, Inc. Terminates Arthur Krieg, M.D., as Senior Vice President and Chief Scientific Officer
07/24/14

Corporate Governance Committee* - sarepta therapeutics inc (AB3A)

Name (Connections)Board RelationshipsTitle
Anthony Chase 185 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Gil Price M.D. 12 RelationshipsInterim Chairman, Chairman of Audit Committee and Member of Compensation Committee
Hans Wigzell M.D., Ph.D. 134 RelationshipsDirector, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
AB3A and Competitor
Insiders vs. External
Board
0%
100%
Sarepta Therapeutics, Inc.
7%
93%
Gilead Sciences Inc.
29%
71%
Hemispherx Biopharma, Inc.
8%
92%
Baxter International Inc.
17%
83%
SciClone Pharmaceuticals, Inc.
15%
85%
AstraZeneca PLC
Insiders
External Board Members

Executive Committee* - sarepta therapeutics inc (AB3A)

Name (Connections)Board RelationshipsTitle
Denis Burger Ph.D. 47 RelationshipsFormer Chairman of the Board, Chief Executive Officer and Member of Executive Committee
K. Forrest 13 RelationshipsFormer Director and Member of Compensation Committee
Alan Timmins 16 RelationshipsFormer President and Chief Operating Officer
Dwight Weller Ph.D. 0 RelationshipsFormer Senior Vice President of Chemistry & Manufacturing
Management Effectiveness Relative to the Industry
Return on Equity
NM
Return on Assets
24.1x
Return on Total Capital
NM
TEV/Total Revenue(LTM)
NM

Advisory Committee* - sarepta therapeutics inc (AB3A)

Name (Board Relationships)/Title Board Affiliations
Hans Wigzell 134 Relationships
Chairman of the Corporate Strategy Board, Director and Member of Nominating & Corporate Governance Committee
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AB3A:GR €12.06 EUR -0.448

AB3A Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AstraZeneca PLC 4,750 GBp -78.50
Baxter International Inc $69.91 USD -0.24
Gilead Sciences Inc $101.38 USD -1.96
Hemispherx Biopharma Inc $0.23 USD -0.0016
SciClone Pharmaceuticals Inc $8.88 USD +0.05
View Industry Companies
 

Industry Analysis

AB3A

Industry Average

Valuation AB3A Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 57.0x
Price/Book 2.2x
Price/Cash Flow NM Not Meaningful
TEV/Sales 34.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SAREPTA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.